Ginsenoside Rb1 alleviates diabetic kidney podocyte injury by inhibiting aldose reductase activity
出版年份 2021 全文链接
标题
Ginsenoside Rb1 alleviates diabetic kidney podocyte injury by inhibiting aldose reductase activity
作者
关键词
-
出版物
ACTA PHARMACOLOGICA SINICA
Volume 43, Issue 2, Pages 342-353
出版商
Springer Science and Business Media LLC
发表日期
2021-11-22
DOI
10.1038/s41401-021-00788-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Panax notoginseng preparations as adjuvant therapy for diabetic kidney disease: a systematic review and meta-analysis
- (2020) Xiuge Tang et al. PHARMACEUTICAL BIOLOGY
- Activation of TRPV1 channel antagonizes diabetic nephropathy through inhibiting endoplasmic reticulum-mitochondria contact in podocytes
- (2020) Xiao Wei et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Ginsenoside Rb1 as an Anti-Diabetic Agent and Its Underlying Mechanism Analysis
- (2019) Ping Zhou et al. Cells
- Ginsenoside Rb1 attenuates diabetic retinopathy in streptozotocin-induced diabetic rats
- (2019) Changxia Dong et al. Acta Cirurgica Brasileira
- Intravenous formulation of Panax notoginseng root extract: human pharmacokinetics of ginsenosides and potential for perpetrating drug interactions
- (2019) Salisa Pintusophon et al. ACTA PHARMACOLOGICA SINICA
- From podocyte biology to novel cures for glomerular disease
- (2019) Elena Torban et al. KIDNEY INTERNATIONAL
- Ginsenoside-Rb1 Improved Diabetic Cardiomyopathy through Regulating Calcium Signaling by Alleviating Protein O-GlcNAcylation
- (2019) Linhui Qin et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Ginsenoside Rb1 mitigates oxidative stress and apoptosis induced by methylglyoxal in SH-SY5Y cells via the PI3K/Akt pathway
- (2019) Fengwei Nan et al. MOLECULAR AND CELLULAR PROBES
- The aldose reductase inhibitor epalrestat exerts nephritic protection on diabetic nephropathy in db/db mice through metabolic modulation
- (2018) Jun He et al. ACTA PHARMACOLOGICA SINICA
- Design, synthesis, structure-activity relationships and X-ray structural studies of novel 1-oxopyrimido[4,5- c ]quinoline-2-acetic acid derivatives as selective and potent inhibitors of human aldose reductase
- (2018) Isidro Crespo et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice
- (2018) Wu Song et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Berberine mitigates high glucose-potentiated platelet aggregation and apoptosis by modulating aldose reductase and NADPH oxidase activity
- (2018) Manoj Paul et al. FREE RADICAL BIOLOGY AND MEDICINE
- Effect of compatible herbs on the pharmacokinetics of effective components of Panax notoginseng in Fufang Xueshuantong Capsule
- (2017) Huan-huan Pang et al. Journal of Zhejiang University-SCIENCE B
- Protein tyrosine phosphatase 1B deficiency in podocytes mitigates hyperglycemia-induced renal injury
- (2017) Yoshihiro Ito et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Renoprotective Effects of Aldose Reductase Inhibitor Epalrestat against High Glucose-Induced Cellular Injury
- (2017) Heba El Gamal et al. Biomed Research International
- Diabetes and Kidney Disease: Role of Oxidative Stress
- (2016) Jay C. Jha et al. ANTIOXIDANTS & REDOX SIGNALING
- Panax notoginseng saponins protect kidney from diabetes by up-regulating silent information regulator 1 and activating antioxidant proteins in rats
- (2015) Yue-guang Du et al. Chinese Journal of Integrative Medicine
- Oxidative stress in chronic vascular disease: From prediction to prevention
- (2015) Francesca Santilli et al. VASCULAR PHARMACOLOGY
- Epalrestat increases glutathione, thioredoxin, and heme oxygenase-1 by stimulating Nrf2 pathway in endothelial cells
- (2015) Kaori Yama et al. Redox Biology
- Molecular mechanisms of diabetic kidney disease
- (2014) Kimberly Reidy et al. JOURNAL OF CLINICAL INVESTIGATION
- Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other microvascular complications: multivariate epidemiological analysis based on patient background factors and severity of diabetic neurop
- (2012) N. Hotta et al. DIABETIC MEDICINE
- Attenuating effect of Fufang Xueshuantong Capsule on kidney function in diabetic nephropathy model
- (2012) Qian Zhang et al. Journal of Natural Medicines
- Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy
- (2012) E. Jennifer Weil et al. KIDNEY INTERNATIONAL
- Aldose Reductase, Oxidative Stress, and Diabetic Mellitus
- (2012) Wai Ho Tang et al. Frontiers in Pharmacology
- Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders
- (2011) Satish K. Srivastava et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Effects of panax notoginoside on the nephropathy in rats with type 1 diabetes mellitus
- (2011) Qing-nian Tu et al. Chinese Journal of Integrative Medicine
- Anti-diabetic effects of Panax notoginseng saponins and its major anti-hyperglycemic components
- (2010) Chang-yong Yang et al. JOURNAL OF ETHNOPHARMACOLOGY
- Saponins Isolated from the Root of Panax notoginseng Showed Significant Anti-Diabetic Effects in KK-Ay Mice
- (2008) Zhong-Hua Chen et al. AMERICAN JOURNAL OF CHINESE MEDICINE
- Aldose Reductase Genotypes and Cardiorenal Complications: An 8-year prospective analysis of 1,074 type 2 diabetic patients
- (2008) W.-Y. So et al. DIABETES CARE
- Ginsenoside Rb1 stimulates glucose uptake through insulin-like signaling pathway in 3T3-L1 adipocytes
- (2008) Wenbin Shang et al. JOURNAL OF ENDOCRINOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started